NCT02662647View on ClinicalTrials.gov

Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

March 31, 2019

Conditions
AML
Interventions
DRUG

Decitabine 20 mg/m²/day for 5 days

Trial Locations (1)

100048

Navy General Hospital, Beijing

All Listed Sponsors
collaborator

Navy General Hospital, Beijing

OTHER

lead

Chinese PLA General Hospital

OTHER

NCT02662647 - Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML | Biotech Hunter | Biotech Hunter